Outcomes and Mutational Analysis of a Prospective Phase II Trial of Azacitidine in Patients with MDS and AML with Early Post-Transplant Relapse

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA(2017)

引用 1|浏览3
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要